$NOVN #Novartis AG Novartis : A pandemic, a launch and a patent challenged in Q2: &gt;Ahead of the guidance - Despite a significant difference compared to expectations, the Q1 2020 results publication is not surprising. The observable trends… https://t.co/O0HTnuFoVY #equity #stocks https://t.co/mABb7gdn03